Showing 8 authorised medicines
Medicine Active substance Licence holder Status
Heparin sodium 1,000 IU/ml Solution for injection or concentrate for solution for infusion, 10ml ampoules PA0281/229/002
Heparin sodium
Pinewood Laboratories Ltd Marketed
Heparin sodium 1,000 IU/ml Solution for injection or concentrate for solution for infusion, 5ml ampoules PA0281/229/001
Heparin sodium
Pinewood Laboratories Ltd Marketed
Heparin sodium 1,000 IU/ml Solution for injection or concentrate for solution for infusion, 5ml vials PA0281/229/004
Heparin sodium
Pinewood Laboratories Ltd Marketed
Heparin Sodium 10 IU/ml flushing solution for maintenance of patency of intravenous devices PA0281/230/001
Heparin sodium
Pinewood Laboratories Ltd Marketed
Heparin sodium 25,000 IU/ml Solution for injection or concentrate for solution for infusion, 0.2ml ampoules PA0281/229/003
Heparin sodium
Pinewood Laboratories Ltd Marketed
Heparin sodium 5,000 IU/ml Solution for injection or concentrate for solution for infusion, 5 ml vials PA0281/229/005
Heparin sodium
Pinewood Laboratories Ltd Marketed
Heparin Sodium BP 1000 IU/l in 0.9% w/v Sodium Chloride IV Infusion PA2299/014/001
Heparin sodium, Sodium chloride, Disodium phosphate dodecahydrate, Citric acid monohydrate
Baxter Holding B.V. Marketed
Heparin Sodium BP 2000 IU/l in 0.9 % w/v Sodium Chloride IV infusion PA2299/014/002
Citric acid monohydrate, Disodium phosphate dodecahydrate, Sodium chloride, Heparin sodium
Baxter Holding B.V. Marketed
Cite this database
Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 5 July 2026).
Copy citation
Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.